Prosecution Insights
Last updated: April 19, 2026
Application No. 18/631,892

SIDE-BY-SIDE ENDOSCOPE AND CAMERA CHANNEL WITH STEERING

Non-Final OA §102§103
Filed
Apr 10, 2024
Examiner
BRUTUS, JOEL F
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Cook Medical Technologies LLC
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
3y 7m
To Grant
90%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allow Rate
922 granted / 1276 resolved
+2.3% vs TC avg
Strong +18% interview lift
Without
With
+18.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
48 currently pending
Career history
1324
Total Applications
across all art units

Statute-Specific Performance

§101
5.9%
-34.1% vs TC avg
§103
47.7%
+7.7% vs TC avg
§102
14.9%
-25.1% vs TC avg
§112
23.6%
-16.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1276 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 3-11 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Igov (Pub. No.: US 2019/0082940) Regarding claim 1, Igov discloses a scope system, comprising: an elongate tube defining a lumen extending longitudinally therethrough, the elongate tube comprising a distal portion [see 0131, 0137] by disclosing an elongated channel having a longitudinal opening will mean the space in the cross section enclosed by the walls of the catheter and line joining the edges of the opening and/or openings [see 0137]; at least one accessory channel comprising at least one tubular structure defining an accessory lumen extending longitudinally therethrough, the at least one accessory channel movably disposed at least partially within the lumen of the elongate tube [see 0131, 0140]; a first steerable endoscopic instrument (a first tool or 734a or pincer tool 734a) extending at least partially through the at least one accessory channel [see 0131-0132, 0208] by disclosing tool 734a includes a forceps [see 0208]; the first steerable endoscopic instrument comprising a first distal instrument end that is movable relative to a distal channel end of the at least one accessory channel [see 0140, 0206, 0208] by disclosing the tool may be moved with respect to the axis of the guide and/or between lumens by twisting a carriage connected and/or inserted in the guide [see 0140, 0208]; a second steerable endoscopic instrument (second tool) extending at least partially through the at least one accessory channel [see abstract, 0142] , the second steerable endoscopic instrument (second tool) comprising a second distal instrument end that is movable (via the second guide) relative to the distal channel end [see abstract, 0041, 0131-0132, 0206] by disclosing the second tool may subsequently be conveyed along a second guide [see abstract] and the catheter further includes a second distal finger for directing a distal end of a second guide of the elongated guides and wherein the control system is further for directing the second finger relative to an axis of the catheter [see 0041]. Regarding claim 3, Igov discloses wherein the first distal instrument end is configured to deflect (via distal finger/guides, 0147, abstract) from a longitudinal axis of the elongate tube in at least two directions [see 0053] by disclosing a plurality of fingers, each the finger including a distal opening of a channel of the plurality of channels; and a control mechanism at a proximal side of the catheter to direct at least two of the fingers in different directions [see 0053] and a user at the proximal end of sleeve 3342 may control tension on cables 3384 to point finger 3382 in one or another direction [see 0286]; wherein a deflection in each of the at least two directions is less than an angle of 180 degrees relative to the longitudinal axis [see 0196]. Regarding claim 4, Igov discloses wherein the second steerable endoscopic instrument is selected from the group consisting of a suction device, an irrigation device, an insufflation device, a camera lens washing device, an electrohydraulic lithotripsy probe, forceps [see 0208], a basket, snares, electrosurgical devices, wires, a dilation balloon, an extraction balloon, a needle knife, hemostasis clips, and laser-based devices. Regarding claim 5, Igov discloses wherein the second steerable endoscopic instrument comprises a steerable sheath (outer sleeve) [see 0220]. Regarding claim 6, Igov discloses wherein the second steerable endoscopic instrument comprises an outer sheath comprising two or more steering wires [see 0220] by disclosing outer sleeve 1242 includes a working channel 1228 and a plurality of guides 1232 [see 0220]. Regarding claim 7, Igov discloses wherein the second distal instrument end is configured to deflect (pointing fingers 3282 and/or guides) from a longitudinal axis of the elongate tube in at least two directions [see 0283, 0325] by disclosing a user at the proximal end of sleeve 3342 may control tension on cables 3384 to point finger 3382 in one or another direction [see 0286]; wherein a deflection in each of the at least two directions is less than an angle of 180 degrees relative to the longitudinal axis [see 0196] Regarding claim 8, Igov discloses wherein the first steerable endoscopic instrument and/or the second steerable endoscopic instrument comprises a steering mechanism (guides/fingers) [see 0144, 0191] Regarding claim 9, Igov discloses wherein the steering mechanism is selected from the group consisting of a joystick, a rack and pinion [see 0191], and a thumb wheel. Regarding claim 10, Igov discloses wherein the second steerable endoscopic instrument comprises forceps [see 0208] by disclosing tool 734a includes a forceps that are biased to an open position and tool 734b includes a pushing element to close the forceps of tool 734b. Tools 734a,b may be deployed independently. Optionally tools 734a, b function cooperatively. For example, the forceps may be moved near an object to be grasped and then the pushing element may be used to close the forceps, grasping the object [see 0208] Regarding claim 11, Igov discloses wherein the second steerable endoscopic instrument comprises an actuator or a lever (pushing element) configured to open and close a first jaw and a second jaw of the forceps [see 0208, 0325] by disclosing tool 734a includes a forceps that are biased to an open position and tool 734b includes a pushing element to close the forceps of tool 734b. Tools 734a, b may be deployed independently. Optionally tools 734a, b function cooperatively. For example, the forceps may be moved near an object to be grasped and then the pushing element may be used to close the forceps, grasping the object [see 0208] and also disclose moving a pusher with relation to a pincer may open and/or close the pincer and/or a blade may be moved to cut and/or takes samples [see 0325]. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 2 are rejected under 35 U.S.C. 103 as being unpatentable over Igov (Pub. No.: US 2019/0082940) in view of Dillon et al (Pub. No.: US 2018/0028778). Regarding claim 2, Igov doesn’t disclose wherein the first steerable endoscopic instrument comprises a cholangioscope. Nonetheless, Dillon et al disclose a cholangioscope [see 0035] by disclosing a small-diameter body configured for use as a steerable catheter equipped as a cholangioscope that is dimensioned for navigation through a working channel of a larger endoscope and for operation within the biliary tree of a human patient [see 0035]. Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Igov and Dillon et al by using a cholangioscope; it allows for direct visualization of the bile ducts, improving diagnostic accuracy. Claim(s) 12-17 are rejected under 35 U.S.C. 103 as being unpatentable over Igov (Pub. No.: US 2019/0082940) in view of in view of Surti et al (Pub. No.: US 20170251908) Regarding claim 12, Igov discloses a scope system, comprising: an elongate tube defining a lumen extending longitudinally therethrough, the elongate tube comprising a distal portion [see 0131, 0137] by disclosing an elongated channel having a longitudinal opening will mean the space in the cross section enclosed by the walls of the catheter and line joining the edges of the opening and/or openings [see 0137]; at least two accessory channels, each of the at least two accessory channels comprising at least one tubular structure defining an accessory lumen extending longitudinally therethrough [see figs 7A-C through 9, 187-188]; the at least two accessory channels movably disposed at least partially within the lumen of the elongate tube [see figs 7A-C through 9, 187-188]; a first steerable endoscopic instrument (a first tool or 734a or pincer tool 734a) extending at least partially through a first accessory channel of the at least two accessory channels [see figs 7A-C through 9, 0131-0132, 0208] by disclosing tool 734a includes a forceps [see 0208]; the first steerable endoscopic instrument (forceps 734a/934a) comprising a first distal instrument end that is movable relative to a distal channel end of the at least two accessory channels [see 0140, 0206, 0208] by disclosing the tool may be moved with respect to the axis of the guide and/or between lumens by twisting a carriage connected and/or inserted in the guide [see 0140, 0208]; a second steerable endoscopic instrument (second tool or camera 546a-b) extending at least partially through a second accessory channel [see figs 7A-C through 9, 187-188]; the second steerable endoscopic instrument comprising a second distal instrument end that is movable relative to the distal channel end [see abstract, 0041, 0131-0132, 0206] by disclosing the second tool may subsequently be conveyed along a second guide [see abstract] and the catheter further includes a second distal finger for directing a distal end of a second guide of the elongated guides and wherein the control system is further for directing the second finger relative to an axis of the catheter [see 0041]. Reed et al don’t disclose a coupling mechanism configured to couple the first distal instrument end to the second distal instrument end. Nonetheless, Surti et al disclose a coupling mechanism (pivot arm 104) configured to couple the first distal instrument end to the second distal instrument end [see 0063, fig 14] Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Reed et al and Surti et al by using a coupling mechanism configured to couple the first distal instrument end to the second distal instrument end; ensuring that the accessory channels 112, 114 do not separate significantly from the duodenoscope 102. Regarding claim 13, Reed et al don’t disclose wherein the coupling mechanism comprises a loop on the first distal instrument end, the loop configured to envelop and tighten around the second distal instrument end, or a loop on the second distal instrument end that is configured to envelop and tighten around the first distal instrument end. Nonetheless, Surti et al disclose a loop on the first distal instrument end, the loop configured to envelop and tighten around the second distal instrument end, or a loop on the second distal instrument end that is configured to envelop and tighten around the first distal instrument end [see 0063] by disclosing a variety of other attachment methods may be used such as loops or rings that may be slide along the length of the duodenoscope 102 to a desired location [see 0063, figs 14-15]. Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Reed et al and Surti et al by using a loop on the first distal instrument end, the loop configured to envelop and tighten around the second distal instrument end, or a loop on the second distal instrument end that is configured to envelop and tighten around the first distal instrument end; ensuring that the accessory channels 112, 114 do not separate significantly from the duodenoscope 102 [see 0063]. Regarding claim 14, Igov doesn’t disclose wherein the first steerable endoscopic instrument comprises a cholangioscope. Nonetheless, Surti et al disclose a cholangioscope [see 0063]. Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Igov and Surti et al by using a cholangioscope; it allows for direct visualization of the bile ducts, improving diagnostic accuracy. Regarding claim 15, Igov discloses wherein the second steerable endoscopic instrument is selected from the group consisting of a suction device, an irrigation device, an insufflation device, a camera lens washing device, an electrohydraulic lithotripsy probe, forceps [see 0208], a basket, snares, electrosurgical devices, wires, a dilation balloon, an extraction balloon, a needle knife, hemostasis clips, and laser-based devices. Regarding claim 16, Igov discloses wherein the first steerable endoscopic instrument and/or the second steerable endoscopic instrument comprises a steering mechanism selected from the group consisting of a joystick, a rack and pinion [see 0191], and a thumb wheel. Regarding claim 17, Igov discloses wherein the second steerable endoscopic instrument comprises forceps and a lever configured to open and close a first jaw and a second jaw of the forceps [see 0208, 0325] by disclosing tool 734a includes a forceps that are biased to an open position and tool 734b includes a pushing element to close the forceps of tool 734b. Tools 734a, b may be deployed independently. Optionally tools 734a, b function cooperatively. For example, the forceps may be moved near an object to be grasped and then the pushing element may be used to close the forceps, grasping the object [see 0208] and also disclose moving a pusher with relation to a pincer may open and/or close the pincer and/or a blade may be moved to cut and/or takes samples [see 0325]. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 18 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Reed et al (Pub. No.: US 2022/0095899). Regarding claim 18, Reed et al disclose a method for performing endoscopy in a bile duct of a mammal [see 0006, 0042, 0052], comprising: providing a scope system comprising: an elongate tube defining a lumen extending longitudinally therethrough, the elongate tube comprising a distal portion [see 0066, fig 11]; at least one accessory channel comprising at least one tubular structure defining an accessory lumen extending longitudinally therethrough, the at least one accessory channel movably disposed at least partially within the lumen of the elongate tube [see 0066, fig 11]; a first steerable endoscopic instrument (instrument 1120) extending at least partially through the at least one accessory channel [see 0066, fig 11]; the first steerable endoscopic instrument (instrument 1120 or any one or the one or more expandable members) comprising a first distal instrument end that is movable relative to a distal channel end of the at least one accessory channel [see fig 11, 0066] by disclosing tool 1120 may be rotatable and axially translatable in order to achieve the desired position and angle of approach to a target area. The tool may also be rotatable and axially translatable with respect to a second tool (not shown) which may be passed through a channel of the instrument (not shown). The tool 1120 may be steerable at its tip [see 0066]; a second steerable endoscopic instrument (instrument 1100) extending at least partially through the at least one accessory channel [see 0066, fig 11]; the second steerable endoscopic instrument (instrument 1100 or any one or the one or more expandable members) comprising a second distal instrument end that is movable relative to the distal channel end of the at least one accessory channel [see 0066] by disclosing instrument 1100 extending through a channel guide 1110 of the device 1102 [see 0066] and the device is slidable along the instrument, such that the instrument may be rotated or axially translated while the radial positioning is fixed. In various embodiments, the device 1110 may be fixed along the instrument 1100 [see 0066]; steering the first distal instrument (1120) end and the second distal instrument end (1100) separately within the bile duct [see 0006, 0042, 0052, 0066] by disclosing the use of multiple devices allows for each device to be independently manipulated, allowing them to be axially extended with respect to each other device [see 0078, abstract]. Claim 19 is rejected under 35 U.S.C. 103 as being unpatentable over Reed et al (Pub. No.: US 2022/0095899) in view of Dillon et al (Pub. No.: US 2018/0028778). Regarding claim 19, Reed et al disclose wherein the first steerable endoscopic instrument is selected from the group consisting of a suction device, an irrigation device, an insufflation device, a camera lens washing device, an electrohydraulic lithotripsy probe, forceps, a basket, snares, electrosurgical devices, wires [see 0047], a dilation balloon [see 0047], an extraction balloon, a needle knife, hemostasis clips, and laser-based devices. Reed et al don’t disclose wherein the second steerable endoscopic instrument comprises a cholangioscope. Nonetheless, Dillon et al disclose a cholangioscope [see 0035] by disclosing a small-diameter body configured for use as a steerable catheter equipped as a cholangioscope that is dimensioned for navigation through a working channel of a larger endoscope and for operation within the biliary tree of a human patient [see 0035]. Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Reed et al and Dillon et al by using a cholangioscope; it allows for direct visualization of the bile ducts, improving diagnostic accuracy. Claim 20 is rejected under 35 U.S.C. 103 as being unpatentable over Reed et al (Pub. No.: US 2022/0095899) in view of Surti et al (Pub. No.: US 20170251908). Regarding claim 20, disclose steering the first distal instrument end and the second distal instrument end together within the bile duct. Reed et al don’t disclose translating the second distal instrument end distally through a loop on the first distal instrument end; tightening the loop around the second distal instrument end. Nonetheless, Surti et al disclose translating the second distal instrument end distally through a loop on the first distal instrument end; tightening the loop around the second distal instrument end [see 0063] by disclosing a variety of other attachment methods may be used such as loops or rings that may be slide along the length of the duodenoscope 102 to a desired location [see 0063, figs 14-15]. Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Reed et al and Surti et al by translating the second distal instrument end distally through a loop on the first distal instrument end; tightening the loop around the second distal instrument end; ensuring that the accessory channels 112, 114 do not separate significantly from the duodenoscope 102 [see 0063]. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOEL F BRUTUS whose telephone number is (571)270-3847. The examiner can normally be reached Mon-Sat, 11:00 AM to 7:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Pascal Bui-Pho can be reached at 571-272-2714. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOEL F BRUTUS/ Primary Examiner, Art Unit 3798
Read full office action

Prosecution Timeline

Apr 10, 2024
Application Filed
Nov 29, 2025
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599299
METHOD AND APPARATUS FOR MULTIMODAL SOFT TISSUE DIAGNOSTICS
2y 5m to grant Granted Apr 14, 2026
Patent 12594131
SYSTEM AND METHOD FOR NAVIGATION
2y 5m to grant Granted Apr 07, 2026
Patent 12594124
MEDICAL SYSTEMS AND RELATED METHODS
2y 5m to grant Granted Apr 07, 2026
Patent 12586191
IMAGE PROCESSING APPARATUS, MEDICAL IMAGE DIAGNOSTIC APPARATUS, AND BLOOD PRESSURE MONITOR
2y 5m to grant Granted Mar 24, 2026
Patent 12579496
INTRAOPERATIVE VIDEO REVIEW
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
90%
With Interview (+18.0%)
3y 7m
Median Time to Grant
Low
PTA Risk
Based on 1276 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month